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This presentation assesses the role of liver transplantation in treat-
ing end-stage liver disease today. Most of the unresolved issues in 
human liver transplantation have been developed in two major series, 
the one from Denver and the other from the combined 
Cambridge/Kings College Hospital effort in England. The findings of 
these groups are highlighted, as are the changes in technique that 
have led to considerably improved survival in the past 2 years. 
THE CURRENT STATUS OF HUMAN UVER 
TRANSPLANTATION 
Human Jiver transplantation has developed frustratingly slowly 
since the first liver graft in man was performed in Denver in March 
1963. However, the success rate has improved remarkably in the last 
2 years and the procedure has at last moved out of the developmental 
and experimental phase and become a truly therapeutic procedure in 
Denver. 
The Denver experience can be divided into a First Series of 111 
patients operated on between March 1963 and July 1976 and a Second 
Series of 30 patients from August 1976 through December 1977. The 
reasons for the improved results in the Second Series will be discussed 
later. 
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In the First Series only 28 per cent of the 111 patients survived for 
.[ 1 year. The fact that the number of long-tenn survivors increased only 
slightly during the course of the First Series (11 of the first 50 recipi-
ents - 22 per cent; 20 of the next 61 patients -33 per cent) was 
cause for concern. On the other hand, 45 per cent of the 1 year sur-
vivors from the First Series are currently alive at between 21f, and Bli, 
years.'"11 The 17 patients who died late at between 1 and 6 years were 
usually already in trouble at the 1 year mark." Thus, the 1 year assess-
ment should be a useful guide in predicting long-term survival. The 
details of the patients who died after 1 year, and the causes of death, 
have been presented elsewhere. 12. II 
As a result of these findings and conclusions, surgical manage-
ment policy was changed in mid 1976 and the Second Series was com-
menced. Of the 30 patients in the Second Series, 1 year survival was 
50 per cent with 2 late deaths at 16lAa and 23 months. The majority of 
the patients in the Second Serles, who are cUITently alive, were well 
when asse,sed at the 1 year mark. This, together with a better under-
standing of the biliary tract anastomosis which had been responsible 
for some of the late deaths, should markedly improve the long term 
prognosis in the 1 year survivors. 
There has 8Iso been an improved survival in the other large series 
of CaIne and Williams. There were only 3 one year survivors in their 
first 35 recipients. Of the next 39 patients, 9 have lived for more than 
a year and 6 additional patients are alive with shorter follow Up.4 
The above data have referred only to total replacement or orthotopic 
liver transplants, Although an accessory or additional (heterotopic) 
liver transplant should have some theoretical advantages, only 1 really 
long-tenn survivor has been achieved by Fortner.8 This technique is 
further discussed below. 
The quality of life after liver transplantation has been assessed in 
the Denver patients and ranged from poor to superior. The details are 
presented elsewhere but it is worth re-emphasizing the finding that a 
good long term prognosis was usually evident by 1 year after opera-
tion." 
WHY HAVE THE RESULTS IMPROVED RECENTLY? 
Rejection, Immunosuppression, and Infection 
Rejection is much more difficult to diagnose after liver grafting 
than after kidney transplantation. In addition it is difficult to separate 
rejection (requiring increased immunosuppression) from sepsis, espe-
cially ascending cholangitis (where increased immunosuppression 
would be harmful). The problem was well demonstrated in a series of 
un-immunosuppressed pig liver transplants in a group of animals with 
a low incidence of rejection. 7 Both the Denver and the Cambridge 
groups have emphasized this problem in man. Postoperative hepatic 
dysfunction is no longer so easily ascribed to rejection and frequent 
liver biopsies and cholangiography (transhepatic, T-tube. or retrograde 
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endoscopic) have now become routine in Denver if the explanation of 
postoperative jaundice is not obviousKO~K I. In addition to the Denver 
group,!! Caine has also emphasized the "tendency to over-
immunosuppressed patients" in the past. ~ All the evidence points to 
the liver being less liable to severe rejection than the kidney, with few 
patients dying primarily of rejection. 
Biliary Anastomosis 
The realization that the biliary tract was the Achilles heel of 
human liver transplantation has led to major changes in technique. 
The Denver group have emphasized that the ideal form of biliary 
reconstruction is a choledochocholedochostomy (direct bile duct to bile 
duct anastomosis) using aT-tube stent (Fig. lA).u The advantage of 
retaining the sphincter of Oddi in preventing ascending cholangitis 
has been clearly demonstrated in animal experiments. 7 However, ap-
proximately 50 per cent of patients in the early experience with a cho-
ledochocholedochostomy developed leakage at the site of anastomosis 
with an almost universal mortality. The Denver group recognized the 
need to cut the donor bile duct high enough to insure adequate blood 
supply, as visualized by bleeding from the cut end of the donor duct 
after the vascular anastomoses had been completed, and the impor-
tance of meticulous technique. With these provisos, a direct bile duct 
to bile duct anastomosis is currently the favored technique and, when 
technically feasible, has led to few problems in the Second Series of 
patients. 
When a choledochocholedochostomy is not feasible, the Denver 
group currently prefer either a cholecystojejunostomy or a choledocho-
jejunostomy using a Roux loop (Fig. 1 B and C). Although the chole-
cystojejunostomy has the advantages of a large caliber anastomosis, 
especially in pediatric recipients, and of not requiring a stent, the 
major disadvantage has been obstruction to the cystic duct which has 
q~""K lie ....... _.... 
Figure 1. Techniques of biliary duct reconstruction acceptable to us for most uaDsplan-
tation recipients. A. Choledocbocboledocbostomy. Note that the T-tube II placed. if possible, 
In recipient common duct. B, Cholecystojejunostomy. C, Chol~ochojejunostomy after 
removal oC gallbladder. (FTom Stal·d. T. E.. Koep, L. J .. Halgrimson. C. G., et aL: Uver trans-
plantation. 1978, Transplant Proc .• 1978. in press. By permission.) 
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necessitated reoperation and conversion to a choledochojejunostomy In 
~ to 35 per cent of cases (Fig. 1 B to C), The possible vascular expla· 
nations for this are described below. Furthennore, the Roux limb or 
the jejunostomy below it have developed peri'oration In 8 cases and 
this was the major cause of death In 7 patients. lI • n 
CaIne and Will1ams have also emphasized the problems of the bili· 
ary anastomosis" They have advocated a choledochocboledochostomy 
(Fig. lA) In the past because this provided good anatomical biliary 
drainage as it preserved the )sphincter of Odd!. However, leakage at 
this anastomosis site with high mortality bas led CaIne to develop a 
new technique of biliary anastomosis, which also retains the sphincter ' 
of Odd1, namely gallbladder interposition with the gallbladder acting 
as a conduit (Fig. 2). The anastomosis Is stented with a T-tube which 
Is used for irrigation and allows the biliary system to be studied radio-
logically In the postoperative period,' In designing the new operation, 
CaIne recognized and emphasized the precarious blood supply of the 
donor common bile duct (vide infra). 
However, the implications of the bile duct blood supply in biliary 
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, Figure 2. Diagram sbowing 
the completed anastomoses be-
tween Hartmann's pouch and the 
donor common duct and the fun-
dus and the recipient's common 
duct. The T-tube is splinting both 
anastomoses. (From CaIne. R. Y.: 
A new technique for biliary drain-
age in orthotopic liver transplan-
tation utilizing the gallbladder as 
a pedicle graft conduit between 
the donor and recipient common 
bile ducts- Ann. Surg .. 184 :60S-
609. 1976. By permission.) 
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tract problems were not fully appreciated until the blood supply of the 
human bUe duct was clearly defined. This is emphasized by the fairly 
long donor duct depicted in Figure 2. Calne and Williams have also 
recently emphasized that in using the gallbladder interposition tech-
nique the donor common bile duct must be trimmed back until it 
bleeds, even if the cystic duct has to be ligated and the common hepa-
tic duct cut back until adequate bleeding is noted. ~ 
Northover (who had been involved in the CalneIWilliams Series as 
a young trainee at Kings College Hospital, London) investigated the 
problem of the biliary anastomosis in Cape Town. The Cape Town 
group were intrigued by the fact that a direct bUe duct to bUe duct 
anastomosis seldom gave problems in animals. In assessing the possi-
ble reasons for this fundamental difference between man and animals, 
two factors that would only affect man became evident. They were the 
advanced debility of many of the human transplant recipients when 
compared with the fit experimental animals (which would be difficult 
to quantitate), and the possibility of an anatomic difference in the bile 
duct blood supply between man and the animals used for liver trans-
plant experiments. 13 
The anatomic theory was investigated by developing a refined poly-
ester resin casting-tissue maceration technique and using this to de-
fine the blood supply of the bile duct in the pig and baboon. In addi-
tion, this technique clearly defined the blood supply of the human bile 
duct for the first time. The pig and baboon ducts were shown to be 
well vascularized. The baboon bile duct was supplied axially, as in 
man, but with more profuse vessels of a relatively large caliber supply-
ing the duct, while the pig bUe duct had a very adequate blood supply 
which came in laterally in a pattern similar to the small bowel blood 
supply. This anatomic finding probably accounts for the trouble-free 
bile duct to bUe dUct anastomoses noted in these species. IS In man the 
intrahepatic and retropancreatic portions of the bile ducts were shown 
to have an excellent blood supply from adjacent vessels, but the su-
praduodenal bile duct had a tenuous blood supply and was supplied 
axially by small vessels from below and above. In most cases 3 and 9 
o'clock arteries were present on each side of the bile duct but were of 
small caliber (±O.3 mID average diameter). Two-thirds of the arterial 
input to these vessels came from below and only one-third from above 
from the right hepatic and cystic arteQes. H In addition, a previously 
undescribed major artery. which has been named the retroportal arte-
ry, was found. In 20 per cent of the initial series (one-third of the com-
pleted series) this vessel ascended on the back of the bile duct to join 
the right hepatic artery, but in the remainder, the retroportal artery 
only contributed very small branches to supply the supraduodenal bile 
duct from below (Figs. 3 and 4). The retroportal artery supplying the 
duct, when present, was of larger caliber than the 3 and 9 o'clock arte-
ries (±a. 53 mm average diameter).la. 14 On the basis of these findings, it 
has been suggested that the human donor bile duct is more liable to 
develop ischemia because of the tenuous blood supply from above, 
than the recipient duct which should be well supplied from below. In 
( : 
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f'1&ure 3. Retroportal artell. POiterior views of upper abcIomlDal 0i'PD1 to lbow the 
Ulual c:oJrllprations of this artery. A, ReboporW artery ucendlnC to join the riCbt hepatic 
artery lupplying the common hUe duet en l'Oute (20 per ceDt of lpecimens). I, Retroportal 
llltery jo1nlnl the retroduodenal artery. end HDCtiDI lmaD brancbei to the lupraduodenal 
common hUe duct (60 per cent of lpeeimenl). CA. celiac axis; CBD. common hUe duct; 
IPDA. Inferior pancreadeo-duodenal artery; PV, portal vein; RDA. retroduodenal artery; 
RHA. right hepatic artery; RP A. retIOponal artery; SMA. IUperior meaenterlc artery. (From 
Northover, J., and Terblanche, J.: Bile duct blood lupply. It I Importance in buman liver 
traDsplantation. Tranlplantation, 26:67-69,1978. By permtlllon.) 
---
..t--CBO 
Figure 4. Retl'OponaJ anery. Pbotograpb and drawing of a cast to demonstrate this ves-
sel; in the drawing it is emphasized in black. It arises from the donal pancreatic branch of the 
celiac axis, and In this cue conforms to both patterns Ihown in Figure 3. (From Nortbover. 
J. and Terblancbe. J.: Bile duct blood lupply. Its Importance in buman liver transplantation. 
~KplantationK 26:67-69. 1978. By permission.) 
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the third of patients in whom the retroportal artery was of the type I 
configuration (running up the back of the bile duct to join the right 
hepatic artery), the donor bile duct would be much better supplied 
from above. This study provided an anatomic basis for the bile duct 
probiems noted in many human liver transplant patients. 
These findings also supported the recent recommendations on the 
biliary anastomosis, made by both the Denver and Cambridge groups, 
which have led to considerably fewer bile duct anastomosis problems 
than before. Whether the more complicated approach of an interposed 
gallbladder, as advocated by CaIne, is necessary or desirable will only 
become evident with time. 
McMaster has documented after transplantation a type of sludge 
obstruction in the biliary tree. The obstruction, which consisted of 
amorphous collagen,12 was localized to the donor duct system. This ob-
struction has been attributed to ischemia associated with the donor 
operation, but could well be due to ischemia related to a donor duct 
with poor blood supply. especially if the retroportaI artery did not pro-
vide a major supply to the duct from above as would occur in the Type 
U retroportal artery configuration. u. 14 The 20 to 35 per cent incidence 
of reoperation for obstruction after cholecystojejunostomy (Fig. 1 B) 
might also be related to relative ischemia of the donor duct at and 
below the entry of the cystic duct or of the cystic duct itself. 
Other Technical Modifications 
These have been described in recent publications from Denverl4 , J7 
and Cambridge.4 They include the increasing use of microsurgical 
techniques for both vascular and biliary tract anastomoses especially 
in pediatric recipients, the avoidance of air embolism during the recip-
ient operation,t7 and meticulous attention to detall during the recipient 
operation and anesthesia. 
INDICATIONS FOR UVEa TRANSPLANTATION 
Anyone with chronic end-stage liver disease who is less than 45 or 
50 years old, who is not infected, who has a hopeless prognosis, and 
who does not have widespread malignant disease is a potential candi-
date for liver transplantation. The imProved results currendy being 
achieved after liver transplantation should make the selection of pa-
tients for transplant somewhat easier. 
It is, however, important to emphasize that major differences of 
opinion st1ll exist between the two groups with extensive experience of 
tbisoperation. The main differences are summarized below: 
DfIlICATJON DENVER c.uoJUDC& 
Not favored Favored 
PecUatric patient Favored Not favored 
Cirrhosill Favored ReservatioDII 
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Ace of Recipients 
Calne and Williams do not accept the upper age limit of 45 to 50 
mentioned by the Denver group and have indicated that they have per-
formed liver transplants in patients in their SO's with iood results. 
They emphasize individual considerations and in particular the bioloi-
leal age of the patient.4 There is, in fact., no real diJJerence of opinion 
about the age question as the Denver group is not bound by the arbi-
trary upper age limit. 
Secondary Hepatic MatipaDC)' 
N either group currently considen patients with secondary malig-
nant disease of the liver for transplantation, as all patients receiving 
transplants for this indication in the past have developed recurrent 
malignant disease shortly after transplantation. A nonresectable sec-
ondary malignant growth in the liver is invariably a manifestation of a 
generalized disease process, which rapidly manifests itself in the im-
munosuppressed patient after transplantation . 
Primary Hepatic Malignant Disease 
The Denver group have become increasingly dIsenchanted with 
transplantation for primary hepatic malignant disease. In all, 19 pa-
tients with primary hepatic carcinoma (including hepatocellular carci-
noma, duct cell carcinoma, cbolangiocarcinoma, and angiosarcoma) 
have received transplants in Denver. Recurrences have eventually de-
veloped in 8 of the 9 patients who survived for 3 months or more after 
transplantation. The exception died at 5 months as a result of neuro-
logic complications, but with no evidence of a malignant process at 
post-mortem examination. Five of the 9 survivors lived for over a year, 
and received moderate palliation.11 The only patient cured of hepatic 
carcinoma in Denver was a child who had a small incidental hepa-
toma in the liver which was removed for biliary atresia. She is cur-
rently the longest survivor after liver grafting and is alive at SS/, years 
after transplantation. 
Carcinoma of the main hepatic duct junction has been a major 
area of controversy.SI .•. ,. One of the Denver patients died of metas-
tases more than 2 years post transplant and another is alive more than 
4 years after operation, with proven recurrences. The authors current-
ly agree that this lesion is not usually an indication for liver transplan-
tation today,· although a young patient with a favorable lesion may be 
an exception in the future. 'Ibis view is shared by Caine and Wil-
liams.· The Cape Town group have advocated the use of a replaceable 
V-tube stent, after dilating the lesion, combined with high dose radio-
therapy to the localized area of the tumor.·' 31 The results of dilatation 
and some fonn of intubation with or without radiotherapy in 15 con-
secutive patients, treated in Cape Town between 1968 and January 
1973, and followed prospectively to the present, have been most en-
couraging. Two of the four patients who had the U-tube procedure 
combined with radiotherapy are currently alive and well at over 7 
y~K Two-thirds survived more than 1 year, most of them for pro-
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longed periods, while the average age of the one-third who died early 
was 79 years. If The Denver group currently favor a more aggressive 
approach with resection if possible. With nonresectable lesions one of 
the authors (LJK) has confirmed the Cape Town experience in 6 patients. 
Patients with primary hepatocellular carcinoma are not receiving 
transplants in Denver at present because of the unfavorable past expe-
rience already discussed. CaIne's group, however. feel that most of 
their patients with this lesion have received palliation. Their longest 
survivor died of cholangitis more than 5 years after transplant with no 
evidence of recurrence.· Although the authors do not share CaIne and 
Williams' optimism. they would be prepared to consider a well moti-
vated patient who understood the implications and still requested a 
transplant as a palliative procedure. 
Pediatric Patients 
Pediatric patients constitute an area of major controversy. CaIne 
and Williams do not recommend the procedure in children. In addition 
to their difficulty in obtaining donors. they are concerned about growth 
retardation which is predictable if long term, high dose steroid thera-
py is required.· The Denver group do not agree and recommend liver 
transplantation in children. The majority of children receiving trans-
plants in Denver have had biliary atresia The results have been better 
in pediatric patients in both the First and Second Denver Series (34 
per cent 1 year survival in children versus 20 per cent in adults in the 
First Series. and 58 per cent in children versus 44 per cent in adults in 
the Second Series).!' Pediatric recipients are therefore considered to be 
favored and likely to have a better prognosis. The Cape Town group 
still have reservations, although they concede that a number of chil-
dren have done extremely well in the Denver experience. 1 ' 
Cirrhosis 
The authors believe that the most important f\lture application of 
liver transplantation lies in treating clubosis 01 the liver, particularly 
DOD-alcoholic cirrhosis. Cirrhosis is the major mdication for liver, 
transplantation in adults in Denver.'" M. r. On the other hand, Ca1qe i 
and Williams have some reservations in regard to this indication.· No.' . 
body will deny that there are problems in treatln, cirrhotics by Ji\.ei: 
transplantation. The difliculty of the'operation in cUrhotic patients is 
, hard to describe. The procedure may take 12 to 18 bouts kild require 
the use of literally dozens of liters of blood. The timing of the operation 
In the course of the individual patient'. disease is also difticulL One 
must be certain that the patient bas reached the end stage of the dls-
ease, but the operation must not be delayed until the patient is mori-
bund, otherwise the outcome will inevitably be fatal. Patients with al-
coholic cirrhosis should probably not undergo transplantation unless 
they have clearly given up the abuse of alcohol 
From a technical point of vieW, adult patients with primary biliary 
cirrhosis are ideal candidates. They do not' have severe portal hyper-
tension and their liven are so soft and compliant that the technique is 
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almost comparable in simplicity to that in nonnal animals. It The 
.: Budd-Chiarl syndrome may also constitute a rare but important indica-
tion In some patients, especially if they are deteriorating rapidly and 
not responding to conservative treatment. If However, the authors 
would currently first consider the use of portocaval shunting proce-
dures In patients without Inferior vena caval occlusion.iI. 11 
The ability to stop acute exsanguinating variceal bleeding by the 
combined use of a Sengstaken-Blakemore tube and peresophageal In-
jecdoD sclerotheraPY" might well result In more cirrhotic patients lur-
vivtng long enough to be candidates for liver transplantation. Further-
more, the eradication of esophageal varices and prevention of 
rebleeding using the simple technique of repeated peresophageal1njec-
tion IClerotherapyl' should also Increase the potential pool of cirrhotic 
recipients. 
Inborn Erron of Metaboliam 
Perhaps the most exciting chapter In Jiver transplantation has 
been the ability to cure inbom errors of metabol1sm by liver replace-
ment. At present this applies particularly to alpha.-antitrypsin defi-
ciency and Wilson's disease with severe hepatic dysfunction.a Patients 
with congenital tyrosinemia and type IV glycogen storage disease have 
also undergone transplantation in Denver. The metabolic derange-
ments in all these conditions have been corrected as long as the liver 
functloned. 17 
TISSUE TYPING, UVER PRESERVATION, AND 
IMMUNOSUPPRESSION 
Tissue Typing 
Almost all the matches in the Denver Series have been bad. It has 
never been possible to give tissue typhlg a fair trial in liver grafting, 
because the need for transplantation In appropriate candidates has 
been so pressing that shopping for well matched livers has not been, 
and is unlikely to become, possible. Nevertheless, rejection has not 
been a major problem in liver transplantation. Acute rejection has 
been the primary cause of death in less than 20 per cent of patients in 
the .Denver series, and chronic rejection has occurred in very few of 
the patients who died in the first year." 
Furthennore, hyperacute rejection has surprisingly not been seen 
in the 10 transplants perfonned in Denver in recipients with anti-
donor specific cytotoxic antibodies. Both the Denver and the Cam-
bridge groups have concluded that the liver is a highly privileged 
organ in confrontations with preformed cytotoxic antibodies.24. 21 
Because of the urgency for transplantation in some patients, blood 
group barriers have been breached on 11 occasions. Although this 
should be avoided if possible. hyperacute rejection, which would occur 
commonly in kidneys transplanted under the same circumstances, has 
not been seen except in two exceptional cases. t4 
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Liver Praervation 
Simple hypothennic immersion storage of the liver for up to 8 
hours was first reported using the pig by three groups, including the 
Cape Town group in 1971,.' and by two groups using the baboon in 
, 1970 and 1971. The details of these various simple techniques are 
summarized elsewhere. I. t. 1 •• 1. Short interval simple hypothennic pres-
ervation techniques have had extensive trials in man in both Denver 
and England with the shipment of livers from city to city. The 
Cambridge-Kings College group have used a plasma solution for cold 
infusion of homografts,· while the Denver group have used Collins 80-
lution.·The two techniques have been shown to yield comparable re-
sults and pennit safe preservation of up to 12 hours in dogs. The same 
has been achieved in human beings. t. ~K14K 11 Complicated equipment is 
avoided, contamination by microorganisms is less likely, and transpor-
tation of the small box containing the chilled liver is simple. 
Immunosuppression 
The immunosuppressive regimens of the two major groups have 
'become fairly standardized and include azathioprine (or alternatively 
cyclophosphamide) as well as steroids. The Denver group differ in that 
they often administer anti-lymphOid globulin in addition. 
The major emphasis on non-immunologic factors as the cause of 
failure of liver grafts, as already described, and the apparent lesser 
rejection seen after liver transplantation than with other organ grafts, 
should not lead to the erroneous conclusion that the above immuno-
suppressive regimen is satisfactory. Although overimmunosuppression 
has been a major factor leading to infective problems, some patients 
have had rejection (vide supra). Furthermore, the side-effects of steroids, 
especially in children, constitute another major problem. 
In an effort to reduce steroid requirements and to facilitate "graft 
acceptance," the Denver group have reported on 9 liver recipients 
treated by a thoracic duct fistula.· The fistula was inserted concomi-
tantly with the liver graft In 7 patients and as a later procedure In 2 . 
Five patients are currently alive ~for periods ranging up to 9 months) 
including 3 of the 7 patients receiving concomitant transplant and tho-
racic duct fistula. Five of the patients with concomitant thoracic duct 
ftstula have had either no demonstrable rejection, 01' easily controlled 
episodes of rejection, but unfortunately 2 patients with perfect liver 
function died of infections. The experience to date does not permit def-
inite conclusions. However, thoracic duct fistulas are being routinely 
used at present in recipients of Uver transplants. WI 
An Interesting observation that may have an bnportant bearing on 
the understanding of the immunologic problems of all organ trans-
plants, but especially . the lesser degree of rejection noted in liver 
grafts, bas been made in Uver transplantation in the pig. independent-
ly, Cordier and Garnier and their colleagues in France and Terblanche 
and Peacock of Bristol, England, noted prolonged survival In un-
immunosuppressed unrelated pigs after liver transplantation. t. II. • The 
first really long term survival of an un-immunosuppressed pig with a 
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liver graft from an unrelated donor was presented to the British Surgi-
.:- cal Research Society in November 1966.'· This young pig received a 
transplant on the 15th of June 1966 and weighed 64 pounds at the 
time of transplant. It survived for more than 2 years before dying of an 
unrelated intercurrent vtralinfection. In the meantime It had grown 
normally and ultimately weighed over 700 pounds. This pig confirmed 
the feasibility of perfonning transplants in children, without growth 
retardation, if the hannful 8ide-eft'ects of immunosuppression, espe-
cially steroids, could be avoided. After visiting Bristol to observe the 
technique in the pig. CaIne's group in Cambridge changed from the 
dog to the pig model. They subsequently expanded the study of the 
immunologic manifestations of transplantation in the pig initiated in 
Bristoll ' and undertook a number of elegant and ingenious ttudies 
which have' been summarized in a recent paper.· The work begUn in 
Bristol has been continued and expanded in Cape Townll and else-
where. Although no definitive answers have been forthcoming to date, 
the Cape Town group believe that the pig might yet bold important 
clues to a better understanding of the immunologic manifestations of 
organ transplantation in general. 
HETEROTOPIC UVER TRANSPLANTATION 
Only 43 human heterotopic liver transplants have been reported to 
date.' The disappointing results have already been alluded to, as well 
as the one unique survival of over 5 1/2 years achieved by Fortner.' A 
successful technique of heterotopic liver transplantation would have 
particular application to cirrhotic patients with severe portal hyperten-
sion and extensive vascular collateral vessels which make total remov-
al and replacement of the liver (orthotopic transplantation) extraordi-
narily difficult. One reservation would be the possible late 
development of carcinoma in the diseased cirrhotic liver which would 
still be in situ. 
A number of techniques of placing the graft have been described. 
None has met the ideal criteria for a heterotopic graft, namely direct 
venous drainage of the graft via its superior vena cava. the presence 
of an arterial as well as a venous supply, deviation of the total portal 
venous flow to the donor liver to prevent graft atrophy, and physiologic 
biliary drainage with retention of the sphincter of Oddi. t. to A modifica-
tion of the original Gonzalez technique J has been developed in Cape 
Town and shown to be successful in the pig model. e.' This technique 
has also been shown to be technically feasible in man in a cadaver 
study.' The Cape Town group believe that this new modified technique 
merits a human trial in a limited number of cirrhotic patients in 
whom liver removal is judged to be particularly hazardous. On the 
other hand, the Denver group believe that some kind of auxiliary 
transplant could be used to tide over patients with fulminant hepatic 
failure until their diseased native livers recovered. %7 
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CONCLUSIONS 
Human liver transplantation, which was first performed in man in 
Denver 15 years ago, has finally come of age in the past 2 years. The 1 
year survival has improved from 28 per cent to 50 per cent in the re-
cent Denver Second Series. 
Past experience has shown that long-term prognosis can usually 
be determined based on the 1 year assessment. Patients who are iit 
with a well functioning liver are likely to remain well. This applied to 
the 45 per cent of the 1 year survivors in the First Denver Series, who 
are still alive today at between 26/. and 8'1, years. It has, however, 
been a much more frequent finding in the Second Series, which sug-
gests that a significant number of patients should be long-term SUI-
vivors in the future .. 
Improved survival has been attributed to a number of factors in-
cluding a better understanding of the rejection and infection problems 
In immunosuppressed liver recipients. Postoperative hepatic dysfunc-
tion is no longer as easily ascribed to rejection, and an aggressive 
diagnostic approach has helped to prevent over-immunosuppression. 
Furthermore, new approaches to the biliary anastomosis, and a better 
understanding of the blood supply of the human bile duct, is currendy 
preventing many of the earlier catastrophes related to this, the Achil-
les heel of liver transplantation. 
The indications for liver grafting remain controversial. The best 
survival has been achieved in pediatric recipients in the Denver expe-
lienee, although the issue of liver transplantation in children is not yet 
resolved. The authors believe that the most important future applica-
tion of liver grafting will be in non-alcoholic cirrhosis. 
The liver appears to be a relatively privileged organ in the human 
organ transplant setting. Although, immunosuppressive techniques 
have become standardized, they are not yet ideal. Recent experience 
In Denver with the addition of thoracic duct drainage has been encour-
aging. The pig liver transplant model may yet provide answers to some 
.. unresolved questions in organ transplantation. 
Short-term liver preservation has improved, with simple hypother-
. mk: techniques providing satisfactory storage for up to 12 hours and 
. allowing inter-clty shipment of donor livers. 
Finally, heterotopic liver transplantadon, which has been almost 
uniformly unsuccessful in the past, may still be worthy of consider-
ation under speci1ic conditions if a successful technique can be devel-
oped for use in man. 
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